HIV treatment in children: latest news

HIV treatment in children resources

  • Children

    This factsheet provides some practical information that you might find useful if you are the parent or carer of an HIV-positive child.With the right treatment...

    From: Factsheets

    Information level Level 2
  • Treatment in children

    There is very good evidence that anti-HIV drugs can work well in babies and children, and there have been big falls in the amount of...

    From: Factsheets

    Information level Level 2
  • HIV treatment in children

    An outline of the issues surrounding anti-HIV therapy in children, highlighting the differences from adults in the course of HIV disease, the choice of medications,...

    From: HIV treatments directory

    Information level Level 4
  • HIV treatment

    HIV treatment can mean a longer and healthier life for children with HIV. This treatment consists of taking a combination of three different anti-HIV drugs....

    From: Booklets

    Information level Level 2

HIV treatment in children features

HIV treatment in children news from aidsmap

More news

HIV treatment in children news selected from other sources

  • HIV disappears in 'Los Angeles baby,' doctors say

    The girl, who was born in April and is being referred to as the "Los Angeles baby," remains on three standard HIV medications. Because of this, doctors cannot say for certain yet whether the infant is cured or whether the disease has gone into remission.

    06 March 2014 | Los Angeles Times
  • Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection: What's New

    Key changes made by the Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children (the Panel) to update the November 1, 2012, Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection are summarized below.

    17 February 2014 | AIDSinfo
  • HIV-infected teens delaying treatment until advanced disease, US study shows

    Nearly half of HIV-infected teenagers and young adults forego timely treatment, delaying care until their disease has advanced, which puts them at risk for dangerous infections and long-term complications, according to a study led by the Johns Hopkins Children's Center.

    04 February 2014 | Eurekalert Inf Dis
  • Merck Receives FDA Approval for ISENTRESS(R) (raltegravir) for Pediatric Oral Suspension

    The oral suspension may be used in patients as young as four weeks of age, weighing at least 3 kg to less than 20 kg. The safety and efficacy of ISENTRESS have not been established in infants less than four weeks of age. Formulations of ISENTRESS for specific populations now include oral suspension, chewable tablets and film-coated tablets.

    09 January 2014 | Wall Street Journal
  • Janssen Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children

    Through this program, Janssen will donate its HIV medicines PREZISTA® (darunavir) and INTELENCE® (etravirine), including child-friendly formulations, free of charge to eligible countries with the clinical capacity and willingness to address second- and third-line pediatric HIV treatment. Each child enrolled will receive Janssen’s donated HIV medicines as needed until they turn 19 at which point they will be transitioned into the adult national HIV program or other designated by the national HIV program for continued treatment.

    10 December 2013 | Johnson & Johnson press release
  • Children at risk of AIDS should be tested at birth - UNAIDS

    More than a quarter of a million children each year are born infected with the virus that causes AIDS, but too few are being tested early to receive treatment and prolong their lives, the United Nations said on Wednesday. Michele Sidibe, executive director of UNAIDS, called for diagnostic kits to be improved for detection in babies of the Human Immunodeficiency Virus (HIV) that causes AIDS, and for their "still high" current price of $25-50 to be brought down.

    20 November 2013 | Reuters
  • Older children with HIV may need to start treatment sooner to normalize future CD4 count

    Although younger children with HIV are at high risk of disease progression if not treated, new research published this week in PLOS Medicine indicates that they have good potential for achieving high CD4 counts in later life provided antiretroviral therapy (ART) is initiated according to current treatment guidelines. However, the research also suggests that the recommended CD4 count thresholds for ART initiation are unlikely to maximize immunological health in children who have never received ART before the age of ten years.

    30 October 2013 | EurekAlert
  • UNAIDS reports a 52% reduction in new HIV infections among children and a combined 33% reduction among adults and children since 2001

    World closing in on Millennium Development Goal 6, globally the AIDS epidemic has been halted and reversed—race is on to reach universal access to HIV treatment.

    23 September 2013 | UNAIDS
  • Long-term study backs early HIV drugs for children

    A landmark five-year trial has strengthened evidence that early use of antiretroviral drugs helps children combat the AIDS virus, doctors reported on Thursday.

    22 August 2013 | FRANCE 24
  • Zimbabwe: Killed for Refusing to Take ARVs

    The trial of a 28-year-old man from Zezani in Beitbridge who was arrested for fatally assaulting his 12-year-old brother for refusing to take his anti-retroviral tablets has been postponed to August 30.

    21 August 2013 | AllAfrica
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also